Safety and Benefits of Using Laryngeal Mask Airway to Keep Airway Potency During Fiber-optic Bronchoscopy
NCT ID: NCT02698007
Last Updated: 2016-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2016-04-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Since the action takes place in the airways and in light of the use of sedation, when performing, the procedure requires caution to keep potent airway and breathing sufficient enough.
Most of the bronchoscopy done without the aid of equipment for advanced airway protection. During the operation done monitoring hemodynamics: such as blood pressure, pulse and respiratory such as percutaneous oxygen saturation and carbon dioxide.
Laryngeal Mask Airway (LMA) - is a tool that has been shown to be effective in securing of airway respiratory activity during positive-pressure ventilation.
Several studies have shown that the use of LMA is a convenient and safe while performing bronchoscopy for airways and lungs. However, most of the studies were for certain patient groups such as children, immuno-compromised patients.
Or benefits and safety LMA in front of intubation during bronchoscopy.
Our aim to assess the safety and efficacy LMA in not mechanically ventilated patients undergoing flexible elective bronchoscopy .
Another objective, to examine whether there is a special group of patients enjoy the LMA more than others.
Patients will be divided randomly into two groups alternately by order, one patient study group and the next one to control.
Study group : LMA is inserted under sedation and used during the procedure.
Control group - performing bronchoscopy under sedation without LMA.
About 50 people are needed each group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A New Insertion Technique for Laryngeal Mask Airway
NCT01749033
Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery
NCT02311153
The Efficacy of Laryngeal Mask Airway Gastro (LMA® Gastro™) in Preventing Hypercarbia in ERCP Patients
NCT07182786
Optimizing Third-Generation Video Laryngeal Mask Position: SaCoVLM™ vs. Fiberoptic Bronchoscope
NCT06750926
Safety and Limitation of the 2nd Generation Laryngeal Mask Airway in the Lithotomy Position: An Obsevational Study
NCT05920447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
without lma
standard fiberoptic bronchoscopy without lma
No interventions assigned to this group
with lma
fiberoptic bronchoscopy with the use of lma
Laryngeal Mask Airway (LMA)
Fiberoptic bronchoscopy with the use of LMA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laryngeal Mask Airway (LMA)
Fiberoptic bronchoscopy with the use of LMA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Competency to sign informed consent.
* Room air oxygen saturation above 95%
* Stable hemodynamically and respiratory during the start procedure.
* Undergoing elective bronchoscopy.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pulmonary Institute,Rabin Medical Center
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0690-15-RMC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.